3-Methylglutaconic Aciduria: A New Variant
1 From the Department of Pediatrics B, Beilinson Medical Center, Petah Tiqva, Sackler School of Medicine, Tel Aviv University, Israel
2 From the Metabolic Unit, Shaare Zedek Medical Center, Jerusalem Israel
3 From the Pediatric Neurology Unit, Beilinson Medical Center, Petah Tiqva, Sackler School of Medicine, Tel Aviv University, Israel
4 From the Pediatric Psychology Unit, Beilinson Medical Center, Petah Tiqva, Sackler School of Medicine, Tel Aviv University, Israel
3-Methylglutaconic aciduria has been described in two distinct syndromes. In one there was deficient 3-methylglutaconyl coenzyme A hydratase in fibroblast extracts where the only clinical manifestation was retarded speech development. In the second syndrome, the enzyme activity was normal but prominent neurological deterioration was noted. We describe two siblings with 3-methylglutaconic aciduria with normal enzyme activity who had choreoathetoid movements, optic atrophy, and mild developmental delay. The boy demonstrated developmental improvement in his second year of life, and his sister developed well, with normal school performance. These patients represent a new clinical variant of the second syndrome with a relatively favorable prognosis.
Key Words: 3-methylglutaconic aciduria metabolism choreoathetoid movements optic atrophy neurological deterioration
Submitted on July 5, 1991
Accepted on November 20, 1991
This article has been cited by other articles:
![]() |
A. Nissenkorn, A. Zeharia, D. Lev, A. Fatal-Valevski, V. Barash, A. Gutman, S. Harel, and T. Lerman-Sagie Multiple presentation of mitochondrial disorders Arch. Dis. Child., September 1, 1999; 81(3): 209 - 214. [Abstract] [Full Text] |
||||





